Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Research analysts at William Blair cut their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a report released on Tuesday, March 11th. William Blair analyst B. Vazquez now forecasts that the company will earn $1.10 per share for the quarter, down from their previous estimate of $1.16. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein's Q2 2025 earnings at $1.17 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.25 EPS, FY2025 earnings at $4.87 EPS, Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.35 EPS and FY2026 earnings at $5.17 EPS.
Several other equities analysts have also commented on HSIC. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Finally, Barrington Research restated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $81.10.
View Our Latest Analysis on HSIC
Henry Schein Price Performance
Shares of Henry Schein stock traded up $1.22 during trading on Thursday, hitting $71.80. 2,009,568 shares of the stock traded hands, compared to its average volume of 1,505,096. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.92 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 2.13 and a beta of 0.90. The firm's fifty day moving average is $74.84 and its 200-day moving average is $72.62. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.49.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.66 earnings per share.
Institutional Investors Weigh In On Henry Schein
A number of large investors have recently made changes to their positions in the business. Versant Capital Management Inc lifted its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the period. Investment Management Corp VA ADV purchased a new position in shares of Henry Schein in the 4th quarter valued at approximately $32,000. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the period. 96.62% of the stock is currently owned by institutional investors.
Henry Schein Company Profile
(
Get Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.